Forum tyltheopylline (CPT), a selective A1 receptor antagonist, or alloxazine (ALX), an AD receptor antagonist that displays slightly greater affinity for A2 receptors, 13 were individually administered to rats and compared to caffeine, both produced sleep suppression qualitatively similar to that produced by caffeine, but of smaller magnitude. However, CPT, a highly selective A1 adenosine receptor antagonist in vitro, produced a degree of CNS stimulation more similar to that observed after caffeine than did ALX. When CPT and ALX were injected together, their sleep suppressant effect was of the same magnitude as that of caffeine.
THE SIGNIFICANCE OF THE PAPER BY BLANCO-CEN-TURION ET AL.
1 MAY BE THAT IT STIMULATES MANY SLEEP RESEARCHERS TO ABANDON A SINGLE-MINDED focus on the basal forebrain as the site of the homeostatic regulation of sleep. The authors, however, do not seem ready to take that step.
The experiments reported 1 set out to test 2 hypotheses originally advanced by Rainnie et al. 2 and expounded upon in Strecker et al. 3 : 1) during prolonged wakefulness, the release of adenosine from cholinergic (ACh) neurons in the basal forebrain (BF) is the signal that controls the homeostatic response in recovery sleep, and 2) that adenosine feedback signal works through inhibition of the same ACh neurons that are wake promoting. Blanco-Centurion et al.
1 disprove these hypotheses. After treating rats with 192-IgG-saporin, they show greater than 95% loss of ACh neurons in the BF. These rats no longer show an increase in BF adenosine levels in response to sleep deprivation, but they still show normal sleep homeostatic responses to sleep deprivation. However, infusion of an agonist of the adenosine A1 receptor induces equivalent sleep responses in lesioned and nonlesioned rats. Thus, as the authors conclude, adenosine released by BF ACh neurons is not the feedback signal in sleep homeostasis, and the ACh neurons in the BF are not the primary transducers of sleep drive. One aspect of the first hypothesis -that the adenosine released in the BF during wake comes from the ACh neurons -is neither proven nor disproven by the experiments. The ACh input is depolarizing and thus enhances activity of neurons generally. Thus, with the loss of the ACh excitation, overall neural activity in the BF should be lower, and the loss of the BF adenosine response to sleep deprivation could be due to lower levels of activity of noncholinergic neurons. The authors do not put forth alternative hypotheses to replace those that their results have called into question.
There is an alternative set of hypotheses for the involvement of adenosine in the homeostatic regulation of sleep. 4 These hypotheses ascribe to adenosine a global feedback role on the cells of the thalamus and cortex that are responsible for generating the EEG slow wave activity that is the hallmark of recovery sleep. Why is this line of reasoning ignored by the authors? I think there are three leading reasons.
First, there has been a tendency for investigators in this area of research to operate from a false assumption illustrated in Strecker et al, 3 "The BF is unique with respect to other arousal areas in that it is only here that AD triggers sleep relative to other regions." Although the paper by Strecker at al. 3 is an excellent review of the research on the putative role of the BF in sleep, there is nothing in that paper or anywhere in the literature that supports the contention that AD only acts in the BF to trigger sleep. And a deeper problem is equating "triggering sleep" with sleep homeostasis.
Second, the mechanisms triggering the onset of sleep are not necessarily the same mechanisms that mediate sleep homeostasis. Blanco-Centurion et al. 1 seem to lack appreciation of the fact that the major quantitative indicator of sleep homeostasis is the magnitude of EEG slow wave activity (SWA), and therefore sleep homeostasis must involve the cellular processes underlying the modulation of EEG SWA. Although SWA is mentioned in their paper, and there is one figure that shows similar SWA responses to sleep deprivation in the lesioned and non-lesioned rats with the expected time frame of 3 to 4 hours, the major variables reported by Blanco-Centurion et al. 1 are accumulated sleep times over the longer periods of 12 to 24 hours. Even if the BF is involved in the triggering or the gating of sleep, which it probably is, that does not translate into its being the regulator of sleep homeostasis as expressed by the intensity of cortical SWA.
Third is a flawed hypothesis that "…AD accumulates during wake, and, because it accumulates, it inhibits neural activity in wake promoting brain regions." (p. 8092) 1 An accumulation of adenosine is highly unlikely. Studies show that released adenosine is metabolized within minutes. [5] [6] [7] Whereas prolonged wakefulness could produce sustained local elevations of adenosine, this would be due to increased, sustained release and not accumulation. With the onset of sleep, the extracellular adenosine levels would be expected to decline within minutes rather than the time frame of hours that characterizes sleep homeostatic responses, unless, of course, adenosine continues to be released as a product of the sleep restorative process, as we have proposed. 4 The hypothesis that we put forward 4 is based on the following four facts: (1) Slow wave activity is an expression of the burst-firing mode of thalamocortical and cortical neurons. 8 (2) The burst-firing mode involves low threshold Ca 2+ channels that are abundantly expressed in the thalamus and the cortex. 9 (3) The hyperpolarization necessary to de-inactivate those channels is achieved by adenosine acting through A 1 receptors that are widely and richly expressed in the cortex and thalamus, and act to increase K + conductance. [10] [11] [12] In our hypothesis, 4 peaks of regional cortical activity during wakefulness result in local depletion of cerebral glycogen reserves and a resulting production and release of adenosine into the extracellular fluids. The excellent microdialysis studies of Porkka-Heiskanen et al. 13 that showed increases in BF adenosine with wakefulness also showed similar increases in cortical adenosine levels. (4) Finally, studies that have delivered adenosine agonists systemically or ICV have produced responses in SWA similar to those induced by sleep deprivation. [14] [15] [16] None of these studies lend preferential support to the hypothesis that adenosine is mediating sleep homeostasis through the BF, or to the hypothesis that it is acting through a more global mechanism in the cortex. However, combined with the present study of Blanco-Centurion et al, 1 the focus should shift to the adenosine actions in the cortex as being the mediator of sleep homeostasis. Certainly the BF and other well-known brainstem structures may be involved in the gating of sleep. The transition to sleep results in global hyperpolarization of the cortex that can then be modulated by adenosine. We would argue, however, that the adenosine responsible for this modulation has not accumulated during prior wakefulness, but rather it is being released during sleep due to the metabolic costs of replenishing cerebral glycogen reserves that were depleted during wake.
